𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-Term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: An uncontrolled, open-label, single-arm follow-on study

✍ Scribed by Joseph C. Gathe Jr; Robin Wood; Ian Sanne; Edwin Dejesus; Schürmann Dirk; Andrzej Gladysz; Cindy Garris; Naomi Givens; Robert Elston; Jane Yeo


Book ID
116371852
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
544 KB
Volume
28
Category
Article
ISSN
0149-2918

No coin nor oath required. For personal study only.